SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

A nationwide FAA ground stop, attributed to an air-traffic-control communications issue, has focused attention on airlines and raised concerns about flight disruptions. Traders are debating the impact on AAL, with some treating the decline as a buying opportunity while speculation about the outages cause remains unconfirmed.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

A nationwide FAA ground stop after an air-traffic-control communications failure is driving attention to Delta and other airlines, with traders weighing potential disruption against Deltas relatively modest share move. Speculation about a cyberattack or other cause remains unconfirmed.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summits FDA decision on ivonescimab for EGFR-mutated lung cancer is driving a binary-event debate: bulls point to strong progression-free survival and improving overall-survival trends, while bears focus on the FDAs stated need for statistically significant overall-survival evidence and the risk of a rejection or delay. Traders are also weighing the drugs broader potential and AstraZenecas backing against the uncertainty of this specific application.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Discussion centers on Starship Flight 15s attempt at a first double recovery and its Starlink satellite deployment. The booster was not caught and landed in the Gulf, prompting debate over whether that was a setback or a prudent safety call; traders were still focused on the planned Ship 42 recovery.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

CEO Paul Gus reported share purchase is drawing attention, though traders remain divided as UPST continues to face pressure. Bears point to debt, credit and interest-rate risks and circulate bankruptcy speculation, while bulls see the insider buying and a possible bank charter as reasons for confidence.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

A rare FAA nationwide ground stop tied to an air-traffic-control communications failure is weighing on United and other airline shares. Traders are weighing potential flight disruption against dip-buying interest, while speculation about the cause remains unconfirmed.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Traders are focused on Trulieves expected Russell index inclusion, with speculation that index-tracking funds could buy shares and some investors positioning ahead of the announcement. Broader cannabis rescheduling remains a recurring sector theme, but the index catalyst is driving the immediate discussion.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

NTLAs sharp selloff is being discussed as occurring without an obvious new company-specific setback; traders point to broader pressure on speculative biotech and small-cap stocks, while others blame short selling and stop-loss activity. The debate centers on whether that weakness overshadows the Lonvo-z HAE data and its pending FDA review, with bullish and bearish views split on the path toward commercialization.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

Almontys newly announced share-repurchase program is drawing attention, with traders welcoming it as a sign management sees value in the shares. The discussion also reflects optimism about Sangdongs production ramp and tungstens strategic-supply outlook, though some remain skeptical about the stocks valuation and execution.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

A nationwide FAA ground stop has prompted speculation that the communications outage could have a cyber angle, putting CrowdStrike and other cybersecurity stocks in focus. Traders debated whether the event could benefit the sector, but a cyber cause has not been confirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CLW back under my cost basis! Mr. Market keeps going crazy. Refinancing done, industry cycle recovering done, some short term Augusta problems really scaring Mr. Market off! Wait and see…

StockTwits for iOS

Clearwater Paper Corp

 back under my cost basis! Mr. Market keeps going crazy. Refinancing done, industry cycle recovering done, some short term Augusta problems really scaring Mr. Market off! Wait and see…

Alessandro Vittoria

@Alessandro_Vittoria literal insanity you didnt take the 2x when you had it. ive followed this company for a decade professionally and theres literally always something. just isnt a very good business at the end of the day and the long term impact of GLP1s on the center of the store + substrate switch are total unknowns.

StockTwits Web

 literal insanity you didnt take the 2x when you had it. ive followed this company for a decade professionally and theres literally always something. just isnt a very good business at the end of the day and the long term impact of GLP1s on the center of the store + substrate switch are total unknowns.

Andre Johnson

@AndreJohnson123 business isn’t worth $23, nor is it worth $13, which is why I haven’t sold and I am buying more. There is a right price for any business, and this company trading at 1.2x its E2027 EBITDA is bonkers. Y’all are treating CLW as if it’s never going to earn a dime ever again and it’s going to be liquidated tomorrow. Even in liquidation equity holders would fetch more than its current market cap. There is no reason why this company should trade at this level. I would be more than happy to put my money elsewhere if you can prove that this company is permanently impaired and will never earn a dime again, thus justifying this ridiculous valuation.

 business isn’t worth $23, nor is it worth $13, which is why I haven’t sold and I am buying more. There is a right price for any business, and this company trading at 1.2x its E2027 EBITDA is bonkers. Y’all are treating CLW as if it’s never going to earn a dime ever again and it’s going to be liquidated tomorrow. Even in liquidation equity holders would fetch more than its current market cap. There is no reason why this company should trade at this level. I would be more than happy to put my money elsewhere if you can prove that this company is permanently impaired and will never earn a dime again, thus justifying this ridiculous valuation.

@Alessandro_Vittoria take a look at $PRL.TSX  and $ENVA as a starting point if you want to look at inexpensive businesses with actual growth history / prospects and competent management

Propel Holdings Inc

Enova International Inc.

 as a starting point if you want to look at inexpensive businesses with actual growth history / prospects and competent management

@AndreJohnson123 5-minute look at each and they don’t scream value to me

 5-minute look at each and they don’t scream value to me

@Alessandro_Vittoria nice, I wish I could analyze a company in 5 minutes that&#39;s pretty amazing. both trade at mid-single digits forward earnings and are growing earnings &gt;30% per year. I think you&#39;re too focused on &quot;deep value&quot; metrics vs. business quality weighed against such metrics.

 nice, I wish I could analyze a company in 5 minutes that's pretty amazing. both trade at mid-single digits forward earnings and are growing earnings >30% per year. I think you're too focused on "deep value" metrics vs. business quality weighed against such metrics.

@AndreJohnson123 agreed. I am a deep value guy and I stay within my circle of competence. I don’t mean to insult your picks, they might be perfectly sound and “value” picks, it’s just that it’s not my expertise, and you wanting me to look at your kind of stuff, while you try to convince me that my kind of stuff is wrong through your lense, doesn’t make much sense. I’ve asked you to convince me on why CLW is not a sound investment but you haven’t made up a good argument for it.

 agreed. I am a deep value guy and I stay within my circle of competence. I don’t mean to insult your picks, they might be perfectly sound and “value” picks, it’s just that it’s not my expertise, and you wanting me to look at your kind of stuff, while you try to convince me that my kind of stuff is wrong through your lense, doesn’t make much sense. I’ve asked you to convince me on why CLW is not a sound investment but you haven’t made up a good argument for it.

@Alessandro_Vittoria it&#39;s just a dogshit business with bad economics, an uncertain demand and therefore pricing future, and I think very questionable mid-cycle earnings potential. it has been poorly run for years and I don&#39;t see that changing meaningfully. i think it&#39;s probably undervalued at this level but I&#39;ve seen all the analyses on this business that you can think of and ultimately I just think these assets are pretty mid and one way or another won&#39;t generate the cash you think they will through a cycle.

 it's just a dogshit business with bad economics, an uncertain demand and therefore pricing future, and I think very questionable mid-cycle earnings potential. it has been poorly run for years and I don't see that changing meaningfully. i think it's probably undervalued at this level but I've seen all the analyses on this business that you can think of and ultimately I just think these assets are pretty mid and one way or another won't generate the cash you think they will through a cycle.

@Alessandro_Vittoria ie more original berkshire hathaway than dempster mill

 ie more original berkshire hathaway than dempster mill